Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial

doi:10.3748/wjg.v25.i17.2110

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12891)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

898

WORD

228

HTML

8312

Figures (1-5)

170

Tables (1-1)

114

Sum=9722

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

947

Download

2222

Sum=3169

May 7, 2019 (publication date) through Jun 23, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. May 7, 2019; 25(17): 2110-2121
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2110

Full Size Figure Download Figure

Figure 1 Trial profile. The probiotics group refers to esomeprazole 20 mg b.i.d. and live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules 500 mg t.i.d. treatment; the placebo group refers to esomeprazole 20 mg b.i.d. and placebo treatment. RDQ: Reflux diagnostic questionnaire.

Citation: Sun QH, Wang HY, Sun SD, Zhang X, Zhang H. Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial. World J Gastroenterol 2019; 25(17): 2110-2121
URL: https://www.wjgnet.com/1007-9327/full/v25/i17/2110.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i17.2110